12 Best IPO Stocks with Huge Upside Potential
On July 6, Maria Llerena, Director of Financial Research at Domini Impact Investments, joined BNN Bloomberg to discuss the recent performance of the technology sector and the outlook for the remainder...
Caris Life Sciences Inc. (CAI)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Zevenbergen Capital Investments Nancy Zevenbergen | 802,083 | $14,293,119 | +32% | 0.33% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $14.56 | 68,000 | $990,080.00 | 704,598 | 2026-05-15 | Filing | |
| $16.15 | 31,050 | $501,426.45 | 49,671 | 2026-05-11 | Filing | |
| $24.09 | 4,184 | $100,792.56 | 9,184 | 2025-11-07 | Filing | |
| $23.85 | 400 | $9,540.00 | 460,777 | 2025-11-07 | Filing | |
| $21.00 | 7,500 | $157,500.00 | 123,591 | 2025-06-20 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $27.16 | 1,400 | $38,017.56 | 99,571 | 2025-12-11 | Filing | |
| $26.56 | 60,850 | $1,616,443.74 | 100,971 | 2025-12-11 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 100,000 | $1,782,000 | 0.04% | |
| 2. | 46,068 | $820,932 | 0.02% | |
| 3. | 25,333 | $430,408 | 0% | |
| 4. | 24,000 | $427,680 | 0.02% | |
| 5. | 1,938 | $34,535 | 0% |
News See All
Is Caris Life Sciences, Inc. (CAI) Stock Positioned for Growth With AI-Driven Precision Medicine Expansion?
TheFly reported on June 1 that Wolfe Research analyst Mike Polark initiated coverage of CAI and lowered the stock’s rating to Peer Perform from Outperform.
10 Most Promising Cancer Stocks According to Wall Street Analysts
Regardless of the state of the economy, the pharmaceutical business has continued to be one of the healthcare market's most robust sectors thanks to the consistent need for medications, vaccinations, ...
Is Caris Life Sciences, Inc. (CAI) A Good Stock To Buy Now?
Is CAI a good stock to buy? We came across a bullish thesis on Caris Life Sciences, Inc. on InfoArb Sheets’s Substack. In this article, we will summarize the bulls’ thesis on CAI.
10 Best New Stocks to Buy With Huge Upside Potential
On June 15, Ed Yardeni, Yarden Research President, appeared on CNBC's 'Squawk Box' to discuss the latest market trends.
Caris Life Sciences, Inc. (NASDAQ:CAI) Q1 2026 Earnings Call Transcript
Operator: Good afternoon, everyone, and welcome to the Caris Life Sciences Q1 2026 Earnings Call. My name is Steven, and I will be your coordinator today.
Caris Life Sciences, Inc. (CAI) Coverage Begins at Neutral as Piper Cites Need for Growth Acceleration
TheFly reported on April 10 that Piper Sandler began coverage of CAI with a Neutral rating and a $21 price target.
Top 10 AI-Powered Biotech Stocks to Buy Right Now
Franklin Equity reported on February 16 that, following a protracted period of uncertainty in the previous year, the biotechnology sector has entered 2026 on a firmer and more stable foundation.
Jefferies Initiates Coverage of Caris Life Sciences Inc. (CAI) With a Buy Rating
Caris Life Sciences Inc. (NASDAQ:CAI) is one of the most oversold healthcare stocks to invest in. Jefferies initiated coverage of Caris Life Sciences Inc.
8 Most Oversold Healthcare Stocks to Invest In
Calling it a textbook classic move, he stated that we had a geopolitical shock and markets sold off hard before snapping right back up, making it the classic V shape.
Hedge Fund Resource Center